Market Overview

Analysis of the 2018 Western European Molecular Imaging Market - Forecast to 2022 -


The "Analysis
of Western European Molecular Imaging Market, Forecast to 2022"

report has been added to's

This study takes a look at the Western European molecular imaging
industry. The geographic scope of the market includes the United
Kingdom, Germany, Italy, Spain, France, Scandinavia, and Benelux.

The market is expected to experience a compound annual growth rate
(CAGR) of 4.5 percent during 2017 to 2022, primarily driven by the
growing incidence of cancer - with breast cancer and lung cancer being
the most common cancers - and the continuing shift from single
modalities to hybrid imaging. France, Germany, and Italy are hotspots
for immediate future, followed by the steadily growing markets of Spain,
Scandinavia, and Benelux.

Apart from the rising incidence of cancer, the greater availability of
novel radiotracers and higher quantitation will drive the molecular
imaging market. On the other hand, the price sensitivity of purchasers
due to insufficient reimbursement and competition from other imaging
modalities will continue to restrain growth.

Key Topics Covered:

1. Executive Summary

2. Scope Of The Study

3. Market Drivers And Restraints

4. Forecast And Trends - Total Molecular Imaging Market

5. Top Global Molecular Imaging Market Trends

6. Growth Opportunities And Companies To Action

7. PET/CT Equipment Segment

8. SPECT/CT Equipment Segment

9. SPECT Equipment Segment

10. Germany Breakdown

11. United Kingdom Breakdown

12. France Breakdown

13. Spain Breakdown

14. Italy Breakdown

15. Scandinavia Breakdown

16. Benelux Breakdown

17. The Last Word

18. Appendix

Companies Mentioned

  • Digirad
  • GE Healthcare
  • Heatlhineers
  • Neusoft
  • Philips Healthcare
  • Siemens
  • Spectrum Dynamics
  • Toshiba

For more information about this report visit

View Comments and Join the Discussion!